Download our guide to the digital therapeutics landscape, key providers, and market trends. Discover how digital health solutions can enhance pharmaceutical outcomes.

The digital therapeutics (DTx) market is experiencing significant growth with a projected CAGR of 25-27% over the next few ...

particularly with the rise of digital therapeutics (DTx) and growing evidence of their clinical benefits. DTx deliver evidence-based therapeutic interventions that are driven by high-quality ...

Hyfe’s CEO Tamsin Chislett spoke with Pharmaceutical Executive about this new technology, along with how digital therapeutics ...

So, when digital therapeutics developers, partners, and other industry stakeholders descended on Boston last week for DTx East, it was anything but a normal industry conference. Editor-in-chief ...

Emerging technologies not only expedite the development of new drugs, but also introduce a completely new class of therapies, such as digital therapeutics (DTx), which are software-based solutions ...

Medicover Hospitals will utilise Lupin Digital Health’s advanced Digital Therapeutics (DTx) platform, Lyfe, licensed as a Class C medical device by the regulator CDSCO, to enhance its cardiac ...

The number of people living with depression, anxiety, and eating disorders has grown fast over the last 30 years. Even as mental health issues rise, treatment remains out of reach for many. Fewer than ...

At a workshop convening digital therapeutics companies at the DTX West meeting in San Mateo, California, stakeholders debated what was necessary to build successful business models in the industry ...